High expression of TNFRSF19 is related to the inferior prognosis in melanoma (48), glioblastoma (49), and colorectal cancers (50), and is reported promoting tumorigenesis via TGFβ signaling pathways in nasopharyngeal carcinoma (51). Here, TNFRSF19 is linked to glioblastoma.